Intravenous lacosamide—An effective add-on treatment of refractory status epilepticus

Lowenstein, 1998, Status epilepticus, N Engl J Med, 338, 970, 10.1056/NEJM199804023381407 Knake, 2009, Status epilepticus: a critical review, Epilepsy Behav, 15, 10, 10.1016/j.yebeh.2009.02.027 Leppik, 1983, Double-blind study of lorazepam and diazepam in status epilepticus, JAMA, 249, 1452, 10.1001/jama.1983.03330350028021 Treiman, 1998, A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group, N Engl J Med, 339, 792, 10.1056/NEJM199809173391202 Möddel, 2009, Intravenous levetiracetam: a new treatment alternative for refractory status epilepticus, J Neurol Neurosurg Psychiatry, 80, 689, 10.1136/jnnp.2008.145458 Limdi, 2005, Efficacy of rapid IV administration of valproic acid for status epilepticus, Neurology, 64, 353, 10.1212/01.WNL.0000149527.47600.5A Patsalos, 2000, Pharmacokinetic profile of levetiracetam: toward ideal characteristics, Pharmacol Ther, 85, 77, 10.1016/S0163-7258(99)00052-2 Mehta, 2005, Case series: treatment with levetiracetam in nonconvulsive status epileptus, Epilepsia, 46, 220 Peters, 2005, Intravenous valproate as an innovative therapy in seizure emergency situations including status epilepticus–experience in 102 adult patients, Seizure, 14, 164, 10.1016/j.seizure.2005.01.002 Kellinghaus, 2009, Intrvenous lacosamide as successful treatment for nonconvulsive status epilepticus after failure of first line therapy, Epilepsy Behav, 14, 429, 10.1016/j.yebeh.2008.12.009 Kellinghaus, 2010, Intravenous lacosamide for treatment of status epilepticus, Acta Neurol Scand